FDA NDC Directory · JSON-LD · Markdown

OSELTAMIVIR PHOSPHATE

NDC 69315-174 · HUMAN PRESCRIPTION DRUG · SUSPENSION

Labeler / ManufacturerLeading Pharma, LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA214949
Dosage form / routeSUSPENSION · ORAL
Active ingredientsOSELTAMIVIR PHOSPHATE (6 mg/mL)
Marketing started20220601
Package count1

External sources

Source: openFDA. Public-domain (CC0).